Quote | Neuralstem Inc. (NYSE:SNCA)
Last: | $ |
---|---|
Change Percent: | -6.54% |
Open: | $1.05 |
Close: | $1.00 |
High: | $1.08 |
Low: | $0.982704 |
Volume: | 449,999 |
Last Trade Date Time: | 02/12/2020 04:43:52 pm |
News | Neuralstem Inc. (NYSE:SNCA)
Alzheimer’s disease (AD) is the most common cause of dementia, a progressively debilitating neurodegenerative disease that results in declining cognitive functions, inability to form new memories, behavioral disorders, and gradual loss of bodily functions. While older age does not cause...
In recent years, biomedical research on topics surrounding longevity and aging has gained a tremendous amount of traction. The biotech industry as well as major pharmaceutical companies, have also jumped onto the bandwagon of discovering ways to alter and reverse the aging process. Currently, ...
Message Board Posts | Neuralstem Inc. (NYSE:SNCA)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Neuralstem Inc. Company Name:
SNCA Stock Symbol:
NYSE Market:
Alzheimer’s disease (AD) is the most common cause of dementia, a progressively debilitating neurodegenerative disease that results in declining cognitive functions, inability to form new memories, behavioral disorders, and gradual loss of bodily functions. While older age does not cause...
In recent years, biomedical research on topics surrounding longevity and aging has gained a tremendous amount of traction. The biotech industry as well as major pharmaceutical companies, have also jumped onto the bandwagon of discovering ways to alter and reverse the aging process. Currently, ...
Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc. - Proposed merger with Leading Biosciences, Inc. expected to close on or about Tuesday, April 27th, 2021 - New combined company, Palisades Bio, expected to begin trading on Nasdaq Capital...